Mad Money

Cramer's lightning round: People doubted this stock, but they're wrong

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Amgen: "I am not going to recommend this stock here."

Sarepta Therapeutics: "I think they're brilliant. I think they've got the right combination. I think that a lot of people doubted them. I think those people are wrong."

Wingstop: "Wingstop is one terrific stock."

Regenxbio: "I will have to do some homework on that."

Visa: "Visa's fantastic."

WP Carey: "It's O. K. That's all I'm going to say."

WATCH: Cramer's lighting round

Cramer's lightning round: People doubted this stock, but they're wrong
VIDEO3:0503:05
Cramer's lightning round: People doubted this stock, but they're wrong

Disclosure: Cramer's charitable trust owns shares of Amgen.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com